Lexicon Pharmaceuticals (STU:LX31) Buildings And Improvements : €4.93 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Lexicon Pharmaceuticals Buildings And Improvements?

Lexicon Pharmaceuticals's quarterly buildings and improvements declined from Sep. 2023 (€5.33 Mil) to Dec. 2023 (€5.07 Mil) and declined from Dec. 2023 (€5.07 Mil) to Mar. 2024 (€4.93 Mil).

Lexicon Pharmaceuticals's annual buildings and improvements increased from Dec. 2021 (€2.01 Mil) to Dec. 2022 (€6.05 Mil) but then declined from Dec. 2022 (€6.05 Mil) to Dec. 2023 (€5.07 Mil).

Lexicon Pharmaceuticals Buildings And Improvements Historical Data

The historical data trend for Lexicon Pharmaceuticals's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexicon Pharmaceuticals Buildings And Improvements Chart

Lexicon Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

53.29

2.01

6.05

5.07

Lexicon Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial															6.00	5.78	5.33	5.07	4.93

Lexicon Pharmaceuticals Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Lexicon Pharmaceuticals (STU:LX31) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lexicon Pharmaceuticals Inc (STU:LX31) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

LXRX:USA

Address

2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381

Website

https://www.lexpharma.com

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Lexicon Pharmaceuticals (STU:LX31) Headlines

No Headlines